103 related articles for article (PubMed ID: 30735462)
21. Provider Payments And The Receipt Of Human Papillomavirus Vaccine Among Privately Insured Adolescents.
Tsai Y; Lindley MC; Zhou F; Stokley S
Health Aff (Millwood); 2018 Oct; 37(10):1587-1595. PubMed ID: 30273036
[TBL] [Abstract][Full Text] [Related]
22. Understanding Barriers to HPV Vaccination: Perspectives From Air Force Family Medicine Physicians and Active Duty Air Force Males.
Halista CE; Kline RJ; Bepko J
Mil Med; 2020 Jun; 185(5-6):e878-e886. PubMed ID: 31808930
[TBL] [Abstract][Full Text] [Related]
23. Provider perceptions of barriers and facilitators of HPV vaccination in a high-risk community.
Javanbakht M; Stahlman S; Walker S; Gottlieb S; Markowitz L; Liddon N; Plant A; Guerry S
Vaccine; 2012 Jun; 30(30):4511-6. PubMed ID: 22561142
[TBL] [Abstract][Full Text] [Related]
24. Human papillomavirus vaccine series completion: Qualitative information from providers within an integrated healthcare organization.
Hudson SM; Rondinelli J; Glenn BA; Preciado M; Chao C
Vaccine; 2016 Jun; 34(30):3515-21. PubMed ID: 26947497
[TBL] [Abstract][Full Text] [Related]
25. Community-based household assessment of human papillomavirus (HPV) vaccination coverage and acceptability - HPV vaccine demonstration program, Cambodia - 2017.
Garon J; Wuddhika IV; Sreenivasan N; Wannemuehler K; Vutthikol Y; Chhorvann C; Loharikar A
Vaccine; 2019 Feb; 37(9):1202-1208. PubMed ID: 30686637
[TBL] [Abstract][Full Text] [Related]
26. Timing of HPV vaccine intervals among United States teens with consideration to the current ACIP schedule and the WHO 2-dose schedule.
Cloessner EA; Stokley S; Yankey D; Markowitz LE
Hum Vaccin Immunother; 2016 Jun; 12(6):1375-80. PubMed ID: 26587886
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and predictors of human papillomavirus vaccination in adolescent girls.
Palli SR; Mehta S; Aparasu RR
J Am Pharm Assoc (2003); 2012; 52(1):52-8. PubMed ID: 22257616
[TBL] [Abstract][Full Text] [Related]
28. Factors associated with human papillomavirus vaccine-series initiation and healthcare provider recommendation in US adolescent females: 2007 National Survey of Children's Health.
Lau M; Lin H; Flores G
Vaccine; 2012 Apr; 30(20):3112-8. PubMed ID: 22425179
[TBL] [Abstract][Full Text] [Related]
29. Acceptability of using standing orders to deliver human papillomavirus vaccines in the outpatient obstetrician/gynecologist setting.
Dempsey AF; Pyrzanowski J; Brewer S; Barnard J; Sevick C; O'Leary ST
Vaccine; 2015 Apr; 33(15):1773-9. PubMed ID: 25731788
[TBL] [Abstract][Full Text] [Related]
30. Parental knowledge gaps and barriers for children receiving human papillomavirus vaccine in the Rio Grande Valley of Texas.
Victory M; Do TQN; Kuo YF; Rodriguez AM
Hum Vaccin Immunother; 2019; 15(7-8):1678-1687. PubMed ID: 31170031
[No Abstract] [Full Text] [Related]
31. Human Papillomavirus Vaccine Uptake: Increase for American Indian Adolescents, 2013-2015.
Jacobs-Wingo JL; Jim CC; Groom AV
Am J Prev Med; 2017 Aug; 53(2):162-168. PubMed ID: 28256284
[TBL] [Abstract][Full Text] [Related]
32. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2019.
Elam-Evans LD; Yankey D; Singleton JA; Sterrett N; Markowitz LE; Williams CL; Fredua B; McNamara L; Stokley S
MMWR Morb Mortal Wkly Rep; 2020 Aug; 69(33):1109-1116. PubMed ID: 32817598
[TBL] [Abstract][Full Text] [Related]
33. Human Papillomavirus Vaccine Uptake in Texas Pediatric Care Settings: A Statewide Survey of Healthcare Professionals.
Javaid M; Ashrawi D; Landgren R; Stevens L; Bello R; Foxhall L; Mims M; Ramondetta L
J Community Health; 2017 Feb; 42(1):58-65. PubMed ID: 27473752
[TBL] [Abstract][Full Text] [Related]
34. Using an Implementation Research Framework to Identify Potential Facilitators and Barriers of an Intervention to Increase HPV Vaccine Uptake.
Selove R; Foster M; Mack R; Sanderson M; Hull PC
J Public Health Manag Pract; 2017; 23(3):e1-e9. PubMed ID: 27902559
[TBL] [Abstract][Full Text] [Related]
35. Attitudes about human papillomavirus vaccine among family physicians.
Riedesel JM; Rosenthal SL; Zimet GD; Bernstein DI; Huang B; Lan D; Kahn JA
J Pediatr Adolesc Gynecol; 2005 Dec; 18(6):391-8. PubMed ID: 16338604
[TBL] [Abstract][Full Text] [Related]
36. Healthcare provider perspectives on the uptake of the human papillomavirus vaccine among newcomers to Canada: a qualitative study.
Rubens-Augustson T; Wilson LA; Murphy MS; Jardine C; Pottie K; Hui C; Stafström M; Wilson K
Hum Vaccin Immunother; 2019; 15(7-8):1697-1707. PubMed ID: 30352005
[TBL] [Abstract][Full Text] [Related]
37. Human papillomavirus vaccines: factors that affect vaccine knowledge and delivery.
Holder NA; Katzenellenbogen R; Middleman AB
J Adolesc Health; 2013 Sep; 53(3):423-5. PubMed ID: 23830089
[TBL] [Abstract][Full Text] [Related]
38. Comparing human papillomavirus vaccine knowledge and intentions among parents of boys and girls.
Lindley MC; Jeyarajah J; Yankey D; Curtis CR; Markowitz LE; Stokley S
Hum Vaccin Immunother; 2016 Jun; 12(6):1519-27. PubMed ID: 27003108
[TBL] [Abstract][Full Text] [Related]
39. Correlates of human papillomavirus vaccine coverage: a state-level analysis.
Moss JL; Reiter PL; Brewer NT
Sex Transm Dis; 2015 Feb; 42(2):71-5. PubMed ID: 25585064
[TBL] [Abstract][Full Text] [Related]
40. Healthcare providers' beliefs and attitudes regarding risk compensation following HPV vaccination.
Kasting ML; Wilson S; Dixon BE; Downs SM; Kulkarni A; Zimet GD
Papillomavirus Res; 2016 Dec; 2():116-121. PubMed ID: 27441302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
